At a glance
ClinicalIndex Comparison RecordN/ACompleted· 191 enrolled
Drug / intervention
lubiprostone +1 moredrug
Likely dose
lubiprostone 24mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Single Dose Lubiprostone Along With Split-dose PEG Solution Without Dietary Restrictions for Bowel Cleansing Prior to Colonoscopy, a Randomized, Double-blind, Placebo Controlled Trial
In Brief
A clinical study evaluating lubiprostone and placebo for Bowel Preparation for Colonoscopy. Completed, enrolled 191 participants across 1 site.
Detailed Summary
The primary outcomes of this procedure will be: 1. The cleanliness of the prep as measured by the Ottawa Scale (attachment a). Secondary outcomes will be: 1. Patient satisfaction with the prep measured by 5 point Likert scale (attachment b); 2. Procedure time; 3. The number and size of polyps detected on examination.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBowel Preparation for Colonoscopy
CountriesUnited States
CollaboratorsTakeda
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2007
Primary CompletionJan 2008
First PostedFeb 2008
TodayJul 2026
First PostedFeb 11, 2008
Enrollment StartOct 1, 2007
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 18.4 years ago
Interventions
lubiprostonedrug
lubiprostone 24mcg gelcap, 1 gelcap taken at noon the day prior to the colonoscopy
placebodrug
placebo gelcap, taken at noon the day prior to the colonoscopy